Amarin Corp. PLC ADR (AMRN): Price and Financial Metrics

Amarin Corp. PLC ADR (AMRN): $4.59

0.05 (+1.10%)

POWR Rating

Component Grades














  • AMRN scores best on the Value dimension, with a Value rank ahead of 95.09% of US stocks.
  • The strongest trend for AMRN is in Stability, which has been heading up over the past 199 days.
  • AMRN's current lowest rank is in the Momentum metric (where it is better than 5.42% of US stocks).

AMRN Stock Summary

  • AMRN's current price/earnings ratio is 1,933.4, which is higher than 99.76% of US stocks with positive earnings.
  • For AMRN, its debt to operating expenses ratio is greater than that reported by just 5.7% of US equities we're observing.
  • With a year-over-year growth in debt of -80.55%, Amarin Corp Plc's debt growth rate surpasses just 2.87% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Amarin Corp Plc, a group of peers worth examining would be JJSF, BCOR, BOMN, GPL, and FMX.
  • AMRN's SEC filings can be seen here. And to visit Amarin Corp Plc's official web site, go to

AMRN Stock Price Chart Interactive Chart >

Price chart for AMRN

AMRN Price/Volume Stats

Current price $4.59 52-week high $9.25
Prev. close $4.54 52-week low $3.36
Day low $4.56 Volume 3,561,700
Day high $4.75 Avg. volume 6,464,542
50-day MA $5.74 Dividend yield N/A
200-day MA $5.70 Market Cap 1.81B

Amarin Corp. PLC ADR (AMRN) Company Bio

Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company was founded in 1989 and is based in Dublin, Ireland.

AMRN Latest News Stream

Event/Time News Detail
Loading, please wait...

AMRN Latest Social Stream

Loading social stream, please wait...

View Full AMRN Social Stream

Latest AMRN News From Around the Web

Below are the latest news stories about Amarin Corp Plc that investors may wish to consider to help them evaluate AMRN as an investment opportunity.

Amarin (AMRN) Q1 2021 Earnings Call Transcript

AMRN earnings call for the period ending March 31, 2021.

Yahoo | April 30, 2021

Amarin Corporation plc 2021 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Amarin Corporation plc in conjunction with their 2021 Q1 earnings call....

SA Transcripts on Seeking Alpha | April 29, 2021

Amarin Q1 2021 Earnings Preview

Amarin (NASDAQ:AMRN) is scheduled to announce Q1 earnings results on Thursday, April 29th, before market open.The consensus EPS Estimate is -$0.04 (-33.3% Y/Y) and the consensus Revenue Estimate is $147.1M (-5.1% Y/Y).Over the last 2 years, AMRN has beaten EPS estimates 88% of the time and has beaten revenue estimates...

Seeking Alpha | April 28, 2021

Is AMRN Stock A Buy or Sell?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]

Yahoo | April 26, 2021

Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks

In this article we presented billionaire Steve Cohen’s top 10 small-cap stock picks. You can skip our detailed discussion on Cohen’s investment philosophy and read Billionaire Steve Cohen’s Top 5 Small-Cap Stock Picks. Steve A. Cohen is the owner of Point72 Asset Management, one of the most successful hedge funds in the U.S. He started […]

Yahoo | April 21, 2021

Read More 'AMRN' Stories Here

AMRN Price Returns

1-mo -22.60%
3-mo -44.77%
6-mo 11.68%
1-year -40.47%
3-year 45.71%
5-year 192.36%
YTD -6.13%
2020 -77.19%
2019 57.53%
2018 239.40%
2017 30.19%
2016 62.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.7204 seconds.